Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 Read more
Trodelvy (sacituzumab govitecan) Granted European Commission Marketing Authorization for Treatment of Metastatic Triple-Negative Breast Cancer in Second Line Read more
FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other Drugs Read more
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 Read more
Nykode Therapeutics (Formerly Vaccibody) Enters Into Multi-target License and Collaboration Agreement With Regeneron Read more
BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma Read more
Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders Read more